Última Hora: "Varoufakis: Fim anunciado do memorando na Grécia não vai terminar com políticas de austeridade - Jornal de Negócios - Portugal" Thu, 26 Apr 2018 09:36:02 GMT    "Autoridades encerram serviço que vendia ataques de DDoS - Exame Informática" Thu, 26 Apr 2018 07:55:05 GMT    "João Taborda da Gama lidera grupo de trabalho para melhorar litigância com o Fisco - Jornal de Negócios - Portugal" Thu, 26 Apr 2018 11:31:00 GMT    "Linha ferroviária convencional ou alta velocidade. Afinal, que confusão é esta? - Jornal de Negócios - Portugal" Thu, 26 Apr 2018 13:23:00 GMT    "Portimão teve «os melhores resultados financeiros de sempre» e dispensa última tranche do FAM - Sul Informacao" Thu, 26 Apr 2018 10:03:48 GMT    "Governo relança turismo sénior no Inatel com 13 mil vagas - Dinheiro Vivo" Thu, 26 Apr 2018 08:37:16 GMT    "Governo quer acabar com despejos por obras profundas - ZAP" Thu, 26 Apr 2018 10:16:16 GMT    "Turistas chegam a passar duas horas nas filas do aeroporto de Lisboa - TVI24" Thu, 26 Apr 2018 10:34:00 GMT    "Teixeira Duarte sobe mais de 3% após anunciar acordo com bancos e plano para vender 500 milhões em activos - Jornal de Negócios - Portugal" Thu, 26 Apr 2018 10:31:21 GMT   "" Thu, 26 Apr 2018 13:44:44 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)
Activo não encontrado Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última TradeRange 52 Semanas[0,000 - 0,000]
Hora da Última TradeN/A - N/APrice-Target 1 AnoN/A
Variação ()Capitalização Bolsista3
Bid / AskN/AEPS0,00
AberturaPER12,69%
MáximoPagamento DividendoN/A
MínimoData Ex-DividendoN/A
Fecho Anterior0,000YieldN/A
VolumeVolume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. - [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

United States Asthma Medication Market Report 2018-2025
The Mobile Herald
United States Asthma Medication market competition by top manufacturers/players, with Asthma Medication sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Dulera, QVAR, Glaxosmithkline ...


Drugmakers Duped Medicaid Rebate Regulators, 3rd Circ. Told
Law360
Streck served as a relator under the qui tam provision of the FCA on behalf of the federal government, 23 states and Washington, D.C., court records show. In addition to Allergan, AstraZeneca and NovoNordisk, the defendants included Amgen Inc., Biogen ...

e mais »

Business Wire (press release)
Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary
Business Wire (press release)
Previously, Mr. Trachtenberg served in similar capacities for Pozen Inc., Aralez's predecessor, which he joined in June 2015. Mr. Trachtenberg formerly served as Deputy General Counsel at Auxilium Pharmaceuticals, Inc., from 2012 through its ...

e mais »

Form PRE 14A GI DYNAMICS, INC. For: May 21
StreetInsider.com
GI DYNAMICS, INC. PO Box 51915. Boston, MA 02205. May 1, 2018. Dear Stockholder: You are cordially invited to attend the 2018 annual meeting of stockholders of GI Dynamics, Inc. (the ?Annual Meeting?), to be held on May 21, 2018, at 6:00 p.m., United ...

e mais »

Desloratadine Market Size, Sales, Growth Drivers, Opportunities, Industry Trends and Forecast to 2023
Healthcare Journal
Key Players covered in this Desloratadine Market research report: Pfizer, Teva, Wante Pharmaceutical?, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough ...

e mais »

Allergy Treatment Market ? Evolving Industry Trends and Key Insights by 2024
Chicago Evening Post
Some of the major market companies in global allergy treatment market are Allergopharma, Allergy Therapeutics, Alerpharma S.A, Allergon AB, Genentech Inc., Allergan, Inc., McNeil Consumer Healthcare, Schering-Plough Corporation, Meda Pharmaceuticals ...

e mais »

Asthma Medication Market Overview, Top Manufactures, Market Size, Industry Growth Analysis & Forecast: 2022
Pharmaceuticals News
Asthma Medication Market is a comprehensive analysis of report provides detailed overview of major challenges, opportunities, current market trends and strategies impacting the global market along with estimates and forecast of revenue and share ...


United States Asthma Medication Market Analysis Report 2018-2025
Facts of Week
United States Asthma Medication market competition by top manufacturers/players, with Asthma Medication sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including Dulera, QVAR, Glaxosmithkline ...

e mais »

LANews By Abhishek Budholiya (press release) (blog)
Upcoming Market Forecast Study to Assess the Expansion of Allergy Treatment Market for 2016-2026 Period
LANews By Abhishek Budholiya (press release) (blog)
Some of the key market players in global allergy treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical ...

e mais »

Pharmaceuticals News
Desloratadine Market Analysis, Share, Industry Growth and Forecasts Till 2022
Pharmaceuticals News
Major geographical regions like North America, China, Europe, Southeast Asia, Japan & India and leading players such as Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc ...

e mais »

Desloratadine Market 2018 Top Key Players, Driver, Outlook, Growth, Supply, Demand, Analysis and Research ...
Pharmaceuticals News
Desloratadine Market Key Players: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical ...

e mais »

Allergy Treatment Market Forecast By End-use Industry 2016-2026
Facts of Week
Some of the key market players in global allergy treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical ...

e mais »

Global Desloratadine Market- By Key Players, Type, Application, Region, and Forecast 2018-2025
Business Services
The Global Desloratadine Market 2018 report is detailed study of overall Desloratadine market including introduction of product, definition, scope, Desloratadine global sale, and forecast up to 2025. The Desloratadine Market report is the extensive ...

e mais »

Healthcare Journal
Desloratadine Market to Set Phenomenal Growth from 2018 to 2022
Healthcare Journal
The study provides company profiling, product picture and specifications, sales, market share and contact information of key manufacturers of United States Desloratadine Market, some of them listed here are Pfizer, Teva, Wante Pharmaceutical, Novartis ...

e mais »

Global Loratadine Market Analysis and Forecast by Recent Trends, Development and Regional Growth Overview to 2022
The Financial Analyst
Loratadine Market Report covers the present scenario and the growth prospects of the Loratadine Industry for 2018-2022. Loratadine Market report analyses the industry potential for each geographical region based on the growth rate, macroeconomic ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.
Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters